The dysregulation of the adaptive immune response in the severe patient group with COVID-19 in Wuhan (China) was probably a pronounced decrease of CD4+, CD8+, and regulatory T cells [33], which hastens the exceptional production of proinflammatory cytokines [1]. The gene discussed is CD4; the disease is COVID-19.